Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

Enbee Trade & Finance Fund Raise

Enbee Trade and Finance Limited allotted 70,00,000 equity shares to promoter Amarr Narendra Galla via a Rights Issue on April 13, 2026. This acquisition represents 0.10% of the company's capital, increasing the promoter's total holding to 4,20,00,000 shares (6.02%).

Source

BSE filing, NSE: ENBETRD. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Enbee Trade & Finance Ltd: key numbers

Share price
₹0.23
Market cap
₹16.04 Cr
Revenue (annual)
₹30.62 Cr
Net profit (annual)
₹12.52 Cr
P/E (TTM)
1.1×Sector 19.8×
Promoter holding
2.18%-9.47% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Enbee Trade & Finance Ltd

All →

Other fund raise announcements

All →
20:28 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value
₹72.00 Cr
19:27 IST NSE
Fund RaiseFlywings Simulator Training Centre Ltd FWSTC

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value
₹68.20 Cr
16:20 IST BSE
Fund RaiseKanel Industries Ltd KANELOIL

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value
₹16.99 Cr
Execution
Rights issue opens 23 November 2026 and closes 30 November 2026
15:05 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.